Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-20-008234
Filing Date
2020-04-07
Accepted
2020-04-07 15:57:43
Documents
3
Period of Report
2020-05-28

Document Format Files

Seq Description Document Type Size
1 PRE 14A formpre14a.htm PRE 14A 1347885
2 image00001.jpg GRAPHIC 86151
3 image00002.jpg GRAPHIC 90507
  Complete submission text file 0001140361-20-008234.txt   1592390
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34207 | Film No.: 20779692
SIC: 2834 Pharmaceutical Preparations